Overall, this was a solid quarter for Compass. Compass is up 71% since the beginning of the year, and at $9.92 per share, has ...

Launch Timeline Still in Flux While the European launch is set for the second half of 2025, the timing for the Compass’ ...

Compass: The small Compass wears a natty set of duds meant to evoke the bigger – and much more expensive) Cherokee and Grand Cherokee. A narrow set of front peepers, wearing a dose of LED ...

Guggenheim restated their buy rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report issued on Wednesday morning,Benzinga reports. They currently have a $12.00 target price ...